To qualify for Ozempic, you typically need a diagnosis of type 2 diabetes. That’s the drug’s FDA-approved use, and it’s the clearest path to getting a prescription covered by insurance. Some doctors also prescribe it off-label for weight loss if your BMI is 30 or higher, or 27 or higher with a weight-related health condition, though insurance rarely covers it for that purpose.
The FDA-Approved Criteria
Ozempic (semaglutide) is approved for three specific uses in adults with type 2 diabetes: improving blood sugar control alongside diet and exercise, reducing the risk of major cardiovascular events like heart attack and stroke in people with established heart disease, and reducing the risk of kidney decline in people with chronic kidney disease. All three indications require an underlying type 2 diabetes diagnosis.
A type 2 diabetes diagnosis is typically confirmed when your A1C level is 6.5% or higher. Your doctor may also use a fasting blood glucose of 126 mg/dL or above, or a random blood glucose of 200 mg/dL or above with symptoms like excessive thirst, frequent urination, or unexplained hunger. You need to be 18 or older, as Ozempic has not been approved for use in children or adolescents.
What Insurance Companies Require
Having a prescription doesn’t guarantee coverage. Most insurance plans require prior authorization for Ozempic, and the bar is higher than just having a diagnosis. Based on forms used by major health plans, your insurer will likely ask your doctor to document several things before approving coverage.
First, you need a confirmed type 2 diabetes diagnosis backed by lab results. Second, most plans require that you’ve already tried metformin for at least three months at an appropriate dose and either didn’t respond well enough or had a medical reason you couldn’t take it. This “step therapy” requirement is one of the most common reasons for initial denial. Your insurer may also ask whether you have established cardiovascular disease or chronic kidney disease, since these conditions align with Ozempic’s expanded FDA approvals and can strengthen the case for coverage.
Plans will also check for disqualifying factors. If the prescription is for weight loss rather than diabetes management, many insurers will deny coverage outright. If you’re already taking another medication in the same drug class (a GLP-1 receptor agonist), that’s also typically a reason for denial.
For refills, your insurer may require evidence that the medication is actually working, such as improved A1C numbers or other documented clinical progress.
Off-Label Use for Weight Loss
Some doctors prescribe Ozempic off-label for weight management, even without a diabetes diagnosis. The general thresholds follow standard obesity treatment guidelines: a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related health condition such as high blood pressure, high cholesterol, obstructive sleep apnea, or polycystic ovary syndrome (PCOS).
This is a legitimate medical practice, but it comes with a significant practical hurdle. Most insurance plans won’t cover Ozempic for weight loss. Without coverage, the out-of-pocket cost can run over $1,000 per month. Novo Nordisk, the manufacturer, makes a related drug called Wegovy that contains the same active ingredient at a higher dose and is FDA-approved specifically for weight management. If weight loss is your primary goal, Wegovy may be a more straightforward path to insurance approval, though coverage varies widely by plan.
Who Cannot Take Ozempic
Certain medical histories disqualify you regardless of your diabetes status or BMI. Ozempic is contraindicated if you or a close family member has a history of medullary thyroid carcinoma, a rare type of thyroid cancer. It’s also off-limits if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a genetic condition that increases the risk of certain tumors. Anyone who has had a serious allergic reaction to semaglutide in the past should not take it.
Your doctor will also evaluate your broader health picture. A history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy complications may affect whether Ozempic is a safe choice for you, even if you technically meet the prescribing criteria.
How to Improve Your Chances of Approval
If you’re pursuing Ozempic through insurance, the process goes more smoothly when your medical records clearly tell the story insurers want to see. That means having recent lab work on file, particularly your A1C and fasting glucose levels. If you’ve tried metformin or another first-line diabetes medication and it wasn’t effective enough, make sure that’s documented with dates and dosages.
If your doctor submits a prior authorization and it’s denied, you have the right to appeal. Denials are common and don’t always mean you won’t eventually get coverage. Your doctor’s office can often resubmit with additional documentation, such as evidence of cardiovascular disease or kidney problems, that strengthens your case under Ozempic’s expanded indications.
For people paying out of pocket, Novo Nordisk offers a savings card that can reduce costs for commercially insured patients, though it doesn’t apply to government insurance programs like Medicare or Medicaid. Compounding pharmacies have also begun offering semaglutide at lower prices, but the quality and dosing consistency of compounded versions is a separate consideration worth discussing with your doctor.